Home › Trial NCT04706962
TH1902 in Patients With Advanced Solid Tumors
- Trial IDNCT04706962
- StatusActive Not Recruiting
- PhasePhase 1
- Study typeInterventional
- SponsorTheratechnologies
- Enrollment70
- Start date2021-03-04
- ConditionsSolid Tumor · TNBC - Triple-Negative Breast Cancer · Hormone Receptor-positive Breast Cancer · Epithelial Ovarian Cancer · Endometrial Cancer · Cutaneous Melanoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.